Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Trichomoniasis Test Gets CE-IVD Mark

NEW YORK (GenomeWeb) – Cepheid said today that the CE-IVD mark has been applied to its Xpert TV molecular test for identifying trichomoniasis, and the test has been launched in Europe.

The CE-IVD Mark enables the Sunnyvale, Calif.-based molecular diagnostics firm to offer the test in markets accepting the CE mark.

The test, which runs on Cepheid's GeneXpert System, is used to detect TV infections in males and females. Trichomoniasis is a nonviral sexually transmitted disease caused by infection with the protozoan parasite Trichomonas vaginalis. The World Health organization has estimated that 160 million cases TV infection are acquired worldwide each year, and only about 30 percent of infected individuals develop any symptoms.

"Xpert TV is the first nucleic acid amplification test to deliver TV results for male urine samples," Cepheid Chairman and CEO John Bishop noted in a statement. "It has been difficult to identify and contain TV infections in men because traditional diagnostic methods are much less sensitive than real-time PCR."

The Xpert Tv test is Cepheid's nineteenth assay to get the CE-IVD mark.

The announcement comes one day after Cepheid said that it had received CE marking for its Xpert Flu/RSV XC, an on-demand molecular test for determination of influenza A and B infection and differentiation of respiratory syncytial virus infection.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.